Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanzhou Roya Biotechnology is a specialized life sciences company based in Lanzhou, China, that focuses on the production and supply of high-quality bovine serum and cell culture reagents. The company provides a comprehensive range of products, including fetal bovine serum (FBS), newborn bovine serum, and specialized media designed for the cultivation of various cell lines such as Vero, HEK293, and CHO. Serving as a critical supplier to the biopharmaceutical and vaccine industries, Lanzhou Roya Biotechnology supports major manufacturers like Sinovac and the Lanzhou Institute of Biological Products. Their operations adhere to GMP-like standards, ensuring the quality and stability required for large-scale vaccine production and drug discovery research. The company also offers custom formulation services and technical support for cell culture optimization. With a history dating back to the mid-1990s, it has established a strong reputation for reliability in the Chinese biotechnology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanzhou Roya Biotechnology.